The authors have made available all the data required to replicate the analysis described in this manuscript. The data can be found in [Table 1](#pone.0237392.t001){ref-type="table"}. For readers interested in the data used in the New York State Retrospective Chart Review study \[Graham et al. 2017\] and information abstracted from charts by trained clinicians, readers can contact that study's corresponding authors Deborah J. Fox (<deb.fox@health.nyc.gov>) and Krishika A. Graham (<kgraham1@health.nyc.gov>) for data requests. Readers interested in the data obtained from the Bronx RHIO can contact their Chief Operating Officer, Kathryn Miller (<kmiller@bronxrhio.org>) for data requests.

Introduction {#sec005}
============

Birth defects surveillance in the United States has historically relied on routine reporting of individual cases from hospitals and other health care providers to congenital malformations registries (CMRs) in accordance with state public health laws and regulations \[[@pone.0237392.ref001]\]. The spread of Zika virus in early 2015 in the Region of the Americas clarified the limitations of this approach for identifying birth defects potentially linked to Zika virus infection, including microcephaly. In response, the U.S. Centers for Disease Control and Prevention (CDC) awarded funding to jurisdictions, including New York City (NYC), to support rapid, active surveillance of Zika-related birth defects \[[@pone.0237392.ref002]\]. In early 2017, as part of the federal funding awarded to jurisdictions, the NYC Department of Health and Mental Hygiene established Zika-related Birth Defects Surveillance. To operationalize "rapid" reporting, trained surveillance staff sent requests to birthing facilities to submit lists of newborns with diagnosis codes consistent with microcephaly and other Zika-related birth defects from electronic medical record (EMR) systems on a quarterly basis. Surveillance staff then requested, reviewed and abstracted the records on each list ("active" surveillance). Continued funding of these rapid and active surveillance components has been discontinued or scaled back in many jurisdictions and the use of new and supplemental data sources for ascertaining birth defects cases are needed.

Health information exchange (HIE) systems facilitate the transfer of timely and detailed electronic data or information, including clinical data from providers, health insurance claims history, and public health data (e.g., immunization registries) across disparate healthcare information systems involved in the delivery of care. HIE systems present opportunities to advance disease surveillance and have been linked to improvements in child and adolescent immunization status \[[@pone.0237392.ref003]\], timeliness of notifiable disease reporting \[[@pone.0237392.ref004]\], reduction of duplicative diagnostic testing and identification of drug seeking behaviors \[[@pone.0237392.ref005]\], and improved identification of high utilizing vulnerable patients returning within 72 hours of initial emergency department discharge \[[@pone.0237392.ref006]\].

New York City is one of a growing number of jurisdictions to have partnerships with HIE systems to facilitate exchange of clinical patient information across healthcare organizations. To identify additional ways to support rapid surveillance of birth defects, the NYC Department of Health and Mental Hygiene evaluated data from an HIE system to detect microcephaly diagnosed at birth during 2013--2015, before known introduction of Zika virus in North America. Suspected cases identified by HIE data were compared with cases identified and confirmed to meet the case definition for microcephaly in a prior study (the New York State Retrospective Chart Review, NYSRCR). The objective of this analysis was to determine the extent to which querying of HIE data could replicate the yield obtained by the NYSRCR study through more labor-intensive and costly approaches involving direct inquiry of hospital records and chart abstraction. The sensitivity, specificity, positive and negative predictive values of querying HIE data for identifying confirmed cases of microcephaly were estimated.

Methods {#sec006}
=======

Data from an HIE system, covering the majority of healthcare provided to the 1.4 million residents in the borough of the Bronx, were queried for *International Classification of Diseases*, *Ninth Revision*, *Clinical Modification* (ICD-9-CM) and *International Classification of Diseases*, *Tenth Revision*, *Clinical Modification* (ICD-10-CM) microcephaly diagnostic codes (ICD-9-CM code 742.1, ICD-10-CM code Q02) on day of birth or during the first two days after birth at three Bronx hospitals for births to NYC resident mothers occurring January 1, 2013--December 31, 2015. All data from the HIE are housed in a store-based system that uses search engine technology to query records. Records were retrieved for all births with a microcephaly diagnostic code in any care setting, and then limited to births with diagnoses occurring 0--2 days from the date of birth. Python programming language was then used to extract pertinent data from medical records. Data on selected elements, including hospital name, medical record number, date of diagnosis, visit type, and date of birth, were extracted in csv format and exported for analysis. During this period, the HIE system had clinical data on 1,538,602 unique patients, with 1,113,852 (78%) reporting a Bronx ZIP code. Cases identified by HIE were classified as suspected cases pending confirmation of the presence of microcephaly. One suspected case born to a non-NYC resident mother was excluded from the analysis.

Suspected cases identified by querying the HIE system were compared with confirmed microcephaly cases previously identified in the NYSRCR study. In that study, which occurred during the Spring of 2016, the New York CMR asked all New York birth hospitals to query their EMR systems to identify newborns with ICD-9-CM and ICD-10-CM codes specifying microcephaly (ICD-9-CM code 742.1, ICD-10-CM code Q02) for the 2013--2015 period. Additional cases were identified through review of diagnoses recorded in hospital discharge administrative data. Medical records for suspected microcephaly cases were obtained, and microcephaly diagnosis was confirmed on chart review by trained clinicians \[[@pone.0237392.ref007]\] using the case definition for overall microcephaly developed by the CDC and the National Birth Defects Prevention Network \[[@pone.0237392.ref008]\]. Some suspected cases did not meet the overall microcephaly case definition and were excluded either because they were misclassified (e.g., macrocephaly, microcephalus), or because both a physician diagnosis and anthropometric information needed to accurately classify head circumference percentile were missing \[[@pone.0237392.ref007]\]. Medical chart review methods such as this are the gold standard for evaluating the data quality of birth defects surveillance systems \[[@pone.0237392.ref009]\].

Cases born to NYC resident mothers were matched for three birth hospitals covered by both data sources on birth hospital name, date of birth, and medical record number. Records were linked using a deterministic approach. Cases were classified as a match if the two records agreed on all identifiers and a nonmatch if the two records disagreed on any of the identifiers. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of HIE data in identifying confirmed cases of microcephaly were calculated and corresponding Clopper-Pearson exact 95% confidence intervals were estimated. Newborn records for suspected cases identified using HIE data but not by NYSRCR were requested and reviewed by trained clinical abstractors to confirm the presence of microcephaly.

We compared the HIE data to data obtained by NYSRCR across multiple dimensions. Using NYSRCR data as the denominator, sensitivity measured the proportion of confirmed microcephaly cases identified by querying the HIE system. Conversely, specificity measured the proportion of non-cases identified. Using the HIE data as the denominator, the positive predictive value and negative predictive value quantified the accuracy of the HIE data classification of suspected cases and non-cases, respectively. The rate of false positives was calculated as the proportion of cases identified by the HIE query with no match in NYSRCR using the total number of suspected cases identified by the HIE query as the denominator. Lastly, to measure the correspondence between the two systems (i.e., the level of agreement that could be expected by chance, based on the marginal frequencies in both systems), a kappa statistic was calculated. All statistical analyses were performed using SAS 9.4 (SAS Institute Inc, Cary, North Carolina).

Results {#sec007}
=======

Forty-three suspected cases of microcephaly were identified through the HIE system and 67 confirmed cases were identified by NYSRCR ([Table 1](#pone.0237392.t001){ref-type="table"}). Overall, the HIE system correctly classified birth records 99.81% (16,878/16,910) of the time (Kappa = 0.71). Thirty-nine cases were found in both systems, resulting in sensitivity of 58.21% (39/67), and specificity of 99.98% (16,839/16,843) ([Table 2](#pone.0237392.t002){ref-type="table"}). The overall positive predictive value for HIE data was 90.70% (39/43). Of the four suspected cases identified by the HIE system but missed by NYSRCR, three were misclassified and one was found to meet the microcephaly case definition after chart review, yielding a 7.00% (3/43) false positive rate. No reason was identified for the missed confirmed case.

10.1371/journal.pone.0237392.t001

###### Microcephaly cases born to NYC resident mothers and diagnosed at ages 0--2 days at three birth hospitals---New York City, January 1, 2013 --December 31, 2015.

![](pone.0237392.t001){#pone.0237392.t001g}

                                                        Confirmed case identified through direct inquiry to hospitals                                             
  --------------------------------------------- ------- --------------------------------------------------------------- ----------------------------------------- --------
  **Suspected case identified in HIE system**   Yes     39                                                              4[^a^](#t001fn002){ref-type="table-fn"}   43
  No                                            28      16,839                                                          16,867                                    
                                                Total   67                                                              16,843                                    16,910

HIE, health information exchange.

^a^Records were requested and reviewed by trained clinical abstractors to confirm the presence of microcephaly. One of 4 cases was found to meet the microcephaly case definition.

10.1371/journal.pone.0237392.t002

###### Evaluation of sensitivity, specificity, and positive and negative predictive values of health information exchange data in identifying confirmed cases of microcephaly---New York City, January 1, 2013--December 31, 2015[^a^](#t002fn002){ref-type="table-fn"}.

![](pone.0237392.t002){#pone.0237392.t002g}

  Measure                                 
  --------------------------------------- ----------------------
  Sensitivity, % (95% CI)                 58.21 (45.52--70.15)
  Specificity, % (95% CI)                 99.98 (99.94--99.99)
  Positive predictive value, % (95% CI)   90.70 (77.86--97.41)
  Negative predictive value, % (95% CI)   99.83 (99.76--99.89)
  Accuracy, % (95% CI)                    99.81 (99.73--99.87)
  Total false positives, % (n)            7.00 (3)

CI, confidence interval.

^a^Measures of sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and total false positives were calculated using microcephaly cases identified through direct inquiry of hospitals followed by medical chart review for comparisons across the two data sources.

Discussion and conclusion {#sec008}
=========================

This analysis sought to evaluate the use of querying HIE data to replace or enhance more labor-intensive microcephaly surveillance approaches involving direct inquiry to hospitals and abstraction of hospital records. Leveraging data from an existing HIE system demonstrated high specificity with few false positives when used to detect cases of microcephaly in three NYC birth hospitals. Querying HIE data identified over half (39/67 = 58%) of the cases; however, approximately 42% (28/67) of confirmed microcephaly cases were missed, potentially because of lack of consistent and complete data documentation within the EMR. In addition, three non-cases (7%) were identified, which is consistent with the 6% of suspected cases that did not meet the microcephaly case definition in the gold standard NYSRCR study. We found no explanation for the one case that was identified by HIE query but missed by NYSRCR, but hypothesize that the microcephaly diagnostic code was recorded in a secondary field that was picked up by the HIE, but not by the reporting hospital's query in the NYSRCR study.

These findings suggest that HIE systems could support the continuation of rapid newborn microcephaly surveillance through near real-time monitoring of clinical data without the burden of managing multiple healthcare settings and systems. The burden on public health departments to request lists of suspected cases, and on hospitals to respond can be high, and may not be cost effective in the absence of an outbreak. Furthermore, in NYC, when using direct inquiry for Zika-related Birth Defects Surveillance, the reporting lag time from birth to issuing requests to hospitals ranged from 0--31 days plus another 28--35 days for receipt of a list of suspected cases, a longer surveillance cycle than could be achieved with an automated monthly HIE report. HIEs might be especially useful for programs that will not continue using rapid case-finding methods initiated in response to the Zika virus outbreaks, or for those that exclusively rely on traditional CMR reporting. Automated monthly querying of HIE systems could be a timely and cost-effective approach to monitor trends in prevalence of microcephaly cases and to detect potential disease outbreaks related to birth defects. Alternatively, where routine direct inquiry is warranted, supplementing existing surveillance methods with timely and automated HIE queries could make systems that rely on hospital inquiry and confirmatory chart review more efficient. Cases identified by both systems could bypass human review so that limited resources could be devoted to investigating cases that are only picked up by one source. For example, the highly specific HIE list of suspected cases could be compared to cases identified by direct inquiry to prioritize cases requiring confirmatory chart review. Using HIE data in this way may also have applications for monitoring other clinical conditions and emerging health threats.

The findings in this report are subject to at least three limitations. First, the detection of cases using HIE data was limited to microcephaly diagnoses queried using a single ICD-CM-9 or ICD-CM-10 code on day of birth or during the first two days after birth. Diagnoses entered into the newborn record later were not captured. Additionally, unlike the NYSRCR, we were not able to classify cases by severity. Accurate identification of complex diagnoses, such as severe microcephaly, requires development of novel detection algorithms that utilize clinically detailed information because diagnostic codes alone (e.g., ICD-CM codes) are limited by suboptimal accuracy in identifying specific birth defects \[[@pone.0237392.ref010], [@pone.0237392.ref011]\]. Microcephaly is a clinical and anthropometrical sign that can be multifactorial with a spectrum of clinical manifestations, making its diagnosis challenging \[[@pone.0237392.ref012]\]. As natural language processing of EMR data improves it may be technologically possible to capture or index clinical notes related to head circumference, for example, but even so that information may not be included in HIE data exchange.

Second, sensitivity was low, suggesting that HIE data would need to be supplemented with direct inquiry of hospitals. An alternative approach could involve conducting confirmatory review of any charts that were not identified by both systems. Differences in reporting birth defects across participating facilities may be responsible for the under-ascertainment of cases we observed. Identifying infants with microcephaly can be challenging because of differences in clinical case definitions, timing and setting of diagnosis, and case methods \[[@pone.0237392.ref013]\]. In fact, despite the increasing adoption and implementation of EMR systems, there has been a lack of standardization in design and structure, as well as in adoption of documentation workflows. Data in these systems have multiple fields for reporting conceptually related information that can vary in format (e.g., as free text or as a diagnostic code). Variation in documentation practices across the three NYC birth hospitals in the HIE system could explain why cases were missed by querying HIE data. Different hospitals may have different workflows in place for coding data and sending information to the HIE. Some hospitals may consistently enter certain data elements (like microcephaly diagnoses) at the point of care whereas other hospitals may be more likely to enter these data elements as post-coded updates upon review after discharge. Depending on how the data gets entered in the EMR, it may trigger a delayed update to the HIE or none at all. These variations call for better standardization of reporting and HIE practices across EMR systems. Continued effort to develop standards for EMR design that will produce clearer documentation of the clinical workflow and requirements for data capture could lessen these challenges and improve how EMR systems can be used for public health surveillance and assist health departments. Furthermore, this analysis queried HIE data only for microcephaly diagnostic codes, but it is possible that clinical signs of microcephaly may appear in the HIE in other forms such as transcribed notes and radiology reports. Future studies could explore the use of natural language processing to parse out clinical signs of microcephaly from unstructured or semi-structured text data.

Third, this analysis only includes cases from three birth hospitals in the HIE system in the Bronx, covering roughly 38% (16,910/44,260) of all births born to NYC resident mothers in the Bronx, which excludes cases from other birth hospitals in the region \[[@pone.0237392.ref014]\]. This limits the generalizability of our results. Jurisdictions considering the use of HIE data to monitor trends in microcephaly or Zika-related birth defects more generally will need to evaluate the sensitivity and specificity of HIE reporting relative to cases identified by their current Zika-related Birth Defects Surveillance systems. Conducting chart review validation studies over time to assess changes in HIE sensitivity and specificity can provide a framework for evaluating the performance of HIE data; activities to improve documentation of congenital microcephaly within EMR systems may occur concurrently.

Given the continued potential for Zika virus exposures by nonimmune women of childbearing age and financial feasibility for jurisdictions to periodically run HIE data queries, jurisdictions may consider collaborating with a local HIE for monitoring ongoing trends of Zika-related birth defects. HIE data can be used to facilitate the rapid collection of critical clinical information but improvements in documentation and reporting practices are needed.

We wish to thank the Congenital Malformations Registry, New York State Department of Health, the Primary Care Information Project, New York City Department of Health and Mental Hygiene, the Division of Prevention and Primary Care, Jocelyn Chacko, Mary Crippen, Dr. Hannah Gould, and Tenzin Tseyang.
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Reviewer \#1:

Comment 1. Thank you for this opportunity to review this paper. As someone who has worked at the federal, state, regional, and organization level on HIE, I found this very interesting. This manuscript was very well written, easy to read, and easy to follow.
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Comment 2. This may have more relevance in other surveillance situations, not just microcephaly. This should be stated.

Response: Thank you for the comment. We completely agree. HIE systems present important opportunities to advance public health surveillance, in ways that can increase timeliness and completeness of public health surveillance. The literature has linked HIE systems to improvements in child and adolescent immunization status, timeliness of notifiable disease reporting, reductions in duplicative diagnostic testing and identification of drug seeking behaviors, and improved identification of high utilizing vulnerable patients returning within 72 hours of initial emergency department discharge. The Introduction of the manuscript now references the literature citing these examples where HIE systems have been used to enhance disease surveillance practices.
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Reviewer \#2:

Comment 1. The study aims at evaluation of Health Information Exchange (HIE) data at three Bronx hospitals in New York City for surveillance and detection of microcephaly cases diagnosed at birth during Jan 1, 2013--Dec 31, 2015 before Zika virus introduction in North America. The use of HIE data along with other data sources for surveillance is a known practice. Methodologically the paper has shown little novelty. The domain, the application and results are interesting, although the sensitivity 58.21%, seems low. I'm also curious to know how the authors deal with missing data in the HIE and the chart reviews. Also, I suggest the authors to discuss potential biases in this study.

Response: In this analysis, the authors did not return to the charts the HIE missed to uncover the reasons why these cases were missed. However, the authors suspect it may be due to a lack of consistent and quality EMR documentation. The authors have now addressed this point in the limitations section of the Discussion.

Minor comments:

Comment 2. Line 61: "these rapid and active surveillance components has" should be "these rapid and active surveillance components have"

Response: We agree. The phrase has been revised and now reads, "these rapid and active surveillance components have...".

Comment 3. Line 88: "was excluded from analysis" should be "was excluded from the analysis"

Response: Revision made. The sentence now reads, "one suspected case born to a non-NYC resident mother was excluded from the analysis".

Comment 4. Line 103: "One of 4 cases meet the microcephaly case definition" should be "One of 4 cases meets the microcephaly case definition"
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Comment 5. Line 166: "First, detection of" should be "First, the detection of"

Response: Change made. The sentence now reads, "First, the detection of cases using HIE data was limited to microcephaly diagnoses queried using a single ICD-CM-9 or ICD-CM-10 code on day of birth or during the first two days after birth".

Reviewer \#3: The authors present an interesting analysis although the manuscript is vague and does not provide enough detail to properly evaluate the work.

Response: Thank you. We are pleased you found the analysis interesting. We have revised the manuscript to address the comments you outline below.

Major comments:
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Response: We have revised the introduction to clarify the objective and rationale for our approach. The manuscript now reads, "The objective of this analysis was to determine the extent to which querying of HIE data could replicate the yield obtained by the NYSRCR study through more labor-intensive and costly approaches, involving direct inquiry of hospital records, querying administrative discharge data, and chart abstraction. The sensitivity, specificity, positive and negative predictive values of querying HIE data for identifying confirmed cases of microcephaly were estimated."

Comment 2. The differences between the two reporting systems needs to be more clearly described. For example, routine reporting relies on a congenital malformation registry that is based on hospital reports (using ICD 10 codes) whereas the rapid reports are based on the same codes but are more frequently obtained from the same hospitals (I\'m assuming that the ICD codes for Zika congenital syndrome has been updated in the routine reporting as well).

Response: Thank you for the comment. In the manuscript, the authors describe 3 reporting systems: 1) routine reporting, 2) direct inquiry of hospitals followed by medical chart review, and 3) querying of HIE data. Routine reporting (\#1) is introduced in the Introduction as relying on hospitals and providers to report individual cases to congenital malformations registries in accordance with state public health laws and regulations. However, the authors did not attempt to compare HIE to routine CMR reporting, which may have led to confusion by the reviewer. Surveillance of birth defects in New York conducted by the New York Congenital Malformations Registry receives reports from hospitals on major birth defects in infants and children diagnosed before the age of 2 years. Thus, routine CMR reporting is not helpful for outbreak detection or case-finding.

The analysis described in this manuscript evaluated the extent to which querying of HIE data (\#2) could replicate the yield obtained in the NYSRCR study through direct inquiry of hospital records (\#3). Using the same criteria (diagnosis codes) and case definition as those used for the NYSRCR study, the authors evaluated the use of querying HIE data to replace direct inquiry of hospitals or enhance direct inquiry of hospitals by confirming cases identified through both systems and identifying additional cases not captured through hospital inquiry. HIE can replace or complement direct inquiry depending on resources available. We have revised the Methods to clarify the reporting systems being compared, and Discussion and Conclusion to more directly address these points and reduce confusion.

Comment 3. It also sounds like it was a capture-recapture approach that was taken for the study? If so, please further describe the approach as it will help the reader understand what has been done and the objective of the study. Nothing is mentioned at all about the analysis - how were the data obtained (in what format), what about basic characteristics of the suspected cases (any information on the mothers, when were they born, etc). Record linkage through what exactly? how were estimates of sensitivity, specificity, etc were estimated - using what type of regression? Sensitivity analysis based on the specificity and sensitivity of the case definitions should also be factored into the estimates.

Response: Thank you for the comment. The authors did not design this as a capture-recapture study. The design of the analysis was a criterion-related validation study where direct inquiry of hospitals followed by medical chart review/abstraction was the "gold standard" model. The study design for this analysis was premised on the assumption that direct inquiry would capture 100% of cases.

The revised manuscript expands on the methods of the analysis to address the concerns of the reviewer. Cases identified using the same microcephaly diagnostic codes born to NYC resident mothers were matched for three birth hospitals covered by both data sources using birth hospital name, date of birth, and medical record number. The select birth hospitals in the Bronx had cases in the NYSRCR that were also in the HIE system. Records were linked and matched using a deterministic approach. Cases were classified as a match if the two records agreed on all identifiers and a nonmatch if the two records disagreed on any of the identifiers. The definitions of sensitivity, specificity, negative predictive value, and positive predictive value are described.

No regression analysis or adjustments to sensitivity and specificity estimates were made. This analysis did not attempt to evaluate the microcephaly case definitions developed by CDC and the National Birth Defects Prevention Network (NBDPN). Our goal was not to see whether the expanded list of ICD-10-CM codes used in Zika Birth Defects Surveillance (ZBDS) captures the entire population of children with congenital microcephaly. Rather, this analysis attempted to apply the same microcephaly diagnostic codes (ICD-9-CM or ICD-10-CM) to two data sources (captured via querying HIE data or through direct inquiry of hospital records) to see if the yield was comparable. A limitation we mention in the discussion is that the HIE diagnosis was required to occur in within 2 days of birth but could have been made at any time during the newborn stay for the NYSRCR study.

Comment 4. Case definitions should be provided as supplemental information.

Response: Thank you for the comment. We have clarified our descriptions of suspected and confirmed cases and now explain that NYSRCR records were defined as non-cases (that is, not confirmed) if they had been misclassified (e.g., macrocephaly, microcephalus) or because both a physician diagnosis and anthropometric information needed to accurately classify head circumference percentile were missing. In addition, we have referred readers to the below reference \[8\] for further information on NBDPN case definitions which is publicly available to interested readers:

National Birth Defects Prevention Network (NBDPN). NBDPN abstractor's instructions. Houston, TX: National Birth Defects Prevention Network; 2016. <http://www.nbdpn.org/docs/NBDPN_Case_Definition-SurveillanceMicrocephaly2016Apr11.pdf>

Comment 5. In terms of data availability, what data are available exactly and how (contact corresponding author)?

Response: Thank you for the inquiry. The authors have made available all the data required to replicate the analysis described in this manuscript. The data can be found in Table 1. For readers interested in the data used in the New York State Retrospective Chart Review study \[Graham et al. 2017\] and information abstracted from charts by trained clinicals, we would refer readers to contact the corresponding authors Deborah J. Fox (<deb.fox@health.nyc.gov>) and Krishika A. Graham (<kgraham1@health.nyc.gov>) for data requests.
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4 Jul 2020

PONE-D-20-00230R1

Evaluation of a health information exchange system for microcephaly case-finding --- New York City, 2013---2015

PLOS ONE

Dear Dr. McVeigh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The Authors are expected to address the comments by Reviewers \#3. In additional to these comments, please address:

Abstract, please add the 95% Cis for sensitivity, PPV and NPV.

Please submit your revised manuscript by Aug 18 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Eric HY Lau, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

The Authors are expected to address the comments by Reviewers \#3. In additional to these comments, please address:

1\. Abstract, please add the 95% Cis for sensitivity, PPV and NPV.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: All comments have been addressed

Reviewer \#3: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: The comments and concerns have been promptly addressed. The paper is acceptable and contributes to the field.

Reviewer \#3: The authors did an impressive job at thoroughly addressing all of the comments. The manuscript is clear and the objectives and approach of the study are well described. I have only a few minor comments that need addressing:

\- In the methods section, it should be stated how the 95% CIs were generated (for Table 2) as well as using a Kappa statistic

\- Table 2 - don\'t include (2013-2015) in column heading

\- Line 256 - Preferable to not start a sentence with And

\- Discussion - An important limitation of using HIE, as mentioned, is the poor sensitivity. The alternative approach (starting line 195), would seem the most reasonable/main way forward, as HIE would need to be supplemented with chart reviews. I would suggest that this should be reworded in terms of alternative approach.

\- Discussion - limitation \#2 - this is an important point for recommendations. There needs to be better standardization of reporting across EMRs, which is likely the root of the problem. I would make an explicit recommendation here.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: No

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0237392.r004

Author response to Decision Letter 1

14 Jul 2020

Dear Academic Editor:

Thank you for inviting us to submit a revised version of our manuscript entitled "Evaluation of a health information exchange system for microcephaly case-finding --- New York City, 2013---2015\" to PLOS ONE. Following is a rebuttal letter that responds to each point raised by the academic editor and reviewers.

Review Comments to the Author

Academic Editor:

The Authors are expected to address the comments by Reviewers \#3. In additional to these comments, please address:

1\. Abstract, please add the 95% Cis for sensitivity, PPV and NPV.

Response: Thank you for the feedback. The authors have added the 95% CI for sensitivity, PPV, and NPV to the abstract. Additionally, the authors have responded and addressed the comments made by all Reviewer \#3 below.

Review Comments to the Author:

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: The comments and concerns have been promptly addressed. The paper is acceptable and contributes to the field.

Response: Thank you -- we are pleased you found that the revised manuscript acceptable for publication and a contribution to the field.

Reviewer \#3: The authors did an impressive job at thoroughly addressing all of the comments. The manuscript is clear and the objectives and approach of the study are well described. I have only a few minor comments that need addressing:

Response: Thank you for the constructive feedback. We have addressed and responded to the minor comments that need addressing.

Comment 1. In the methods section, it should be stated how the 95% CIs were generated (for Table 2) as well as using a Kappa statistic.

Response: That authors have now added a statement to specify that corresponding Clopper-Pearson exact 95% confidence intervals were estimated around the parameters generated in Table 2. Standard logit confidence intervals were initially used for the predictive values but have been modified to reflect more conservative Clopper-Pearson exact 95% confidence intervals. A sentence has also been added to the methods section to indicate that a kappa statistic was calculated to measure correspondence between the two systems. All statistical analyses were performed using SAS 9.4 (SAS Institute Inc, Cary, North Carolina) and can be replicated. The authors state this clearly in the methods section.

Comment 2. Table 2 - don\'t include (2013-2015) in column heading

Response: The authors have removed '(2013-2015)' from the column heading in Table 2.

Comment 3. Line 256 - Preferable to not start a sentence with And

Response: The authors have revised the sentence. The sentence does not start with the word 'And' but now reads, "In fact, despite the increasing adoption and implementation of EMR systems, there has been a lack of standardization in design and structure, as well as in adoption of documentation workflows."

Comment 4. Discussion - An important limitation of using HIE, as mentioned, is the poor sensitivity. The alternative approach (starting line 195), would seem the most reasonable/main way forward, as HIE would need to be supplemented with chart reviews. I would suggest that this should be reworded in terms of alternative approach.

Response: In the discussion, the authors do describe scenarios where HIEs could be used to support newborn microcephaly surveillance. The authors introduce the alternative approach of using HIE data to identify cases requiring confirmatory chart review in scenarios where direct inquiry is warranted. The authors have now reworked the Discussion to describe this alternative approach more clearly. The authors are more explicit about how adding automated HIE reporting to a request and review system could improve efficiency. For systems that do rely on hospital inquiry and confirmatory chart review, cases identified by both systems could bypass human review so that limited resources could be devoted to investigating cases that are only picked up by one source.

Comment 5. Discussion - limitation \#2 - this is an important point for recommendations. There needs to be better standardization of reporting across EMRs, which is likely the root of the problem. I would make an explicit recommendation here.

Response: We completely agree. We have made a recommendation for better standardization of reporting across EMRs to the Discussion. The manuscript now reads, "These variations call for better standardization of reporting and HIE practices across EMR systems. Continued effort to develop standards for EMR design that will produce clearer documentation of the clinical workflow and requirements for data capture could lessen these challenges and improve how EMR systems can be used for public health surveillance and assist health departments".
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PONE-D-20-00230R2

Dear Dr. McVeigh,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Eric HY Lau, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:
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5 Aug 2020

PONE-D-20-00230R2

Evaluation of a health information exchange system for microcephaly case-finding --- New York City, 2013---2015

Dear Dr. McVeigh:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Eric HY Lau

Academic Editor

PLOS ONE

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.
